AIM
CTSO icon

Acrospire Investment Management’s Cytosorbents Corp CTSO Stock Holding History

Acrospire Investment Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,943
Closed -$13K – 356
2017
Q2 		$13K Sell
2,943
-548
-16% -$2.4K 0.01% 1715
2017
Q1 		$16K Sell
3,491
-2,732
-44% -$15.3K 0.01% 1709
2016
Q4 		$34K Buy
6,223
+4,776
+330% +$26.1K 0.01% 1586
2016
Q3 		$9K Buy
+1,447
New +$7.52K 0.01% 1723

Other funds holding CTSO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Acrospire Investment Management's CTSO Position: Q3 2017 in Review

Acrospire Investment Management sold out of Cytosorbents Corp (CTSO) in Q3 2017, closing a stake of 2,943 shares — an estimated $13K sold.

Acrospire Investment Management first reported a position in CTSO in Q3 2016 and held it in 4 quarters. The position peaked at $34K in Q4 2016. 31 funds tracked by Wall St. Rank hold CTSO as of Q3 2017.

  • Acrospire Investment Management reported no remaining Cytosorbents Corp position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 2,943 Cytosorbents Corp shares in Q3 2017, an estimated $13K.
  • Acrospire Investment Management first reported a position in Cytosorbents Corp in Q3 2016 and held it in 4 quarters.
  • Acrospire Investment Management's Cytosorbents Corp position peaked at $34K in Q4 2016.
  • 31 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.